Cryo-Cell Income Taxes 2010-2024 | CCEL

Cryo-Cell income taxes from 2010 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Cryo-Cell Annual Income Taxes
(Millions of US $)
2023 $-4
2022 $1
2021 $1
2020 $1
2019 $1
2018 $4
2017 $1
2016 $-1
2015 $-7
2014 $0
2013 $0
2012 $2
2011 $0
2010 $-2
2009 $0
Cryo-Cell Quarterly Income Taxes
(Millions of US $)
2024-08-31 $0
2024-05-31 $1
2024-02-29 $0
2023-11-30 $-5
2023-08-31 $0
2023-05-31 $0
2023-02-28 $0
2022-11-30 $-0
2022-08-31 $0
2022-05-31 $0
2022-02-28 $0
2021-11-30 $-1
2021-08-31 $0
2021-05-31 $0
2021-02-28 $0
2020-11-30 $1
2020-08-31 $0
2020-05-31 $0
2020-02-29 $0
2019-11-30 $0
2019-08-31 $0
2019-05-31 $0
2019-02-28 $0
2018-11-30 $1
2018-08-31 $0
2018-05-31 $0
2018-02-28 $3
2017-11-30 $0
2017-08-31 $0
2017-05-31 $0
2017-02-28 $0
2016-11-30 $-0
2016-08-31 $-1
2016-05-31 $0
2016-02-29
2015-11-30 $-0
2015-08-31 $-7
2015-05-31 $0
2015-02-28 $0
2014-11-30 $0
2014-08-31 $0
2014-05-31 $0
2014-02-28 $0
2013-11-30 $0
2013-08-31 $0
2013-05-31 $0
2013-02-28 $0
2012-11-30 $0
2012-08-31 $0
2012-05-31 $2
2012-02-29 $0
2011-11-30 $0
2011-08-31 $0
2011-05-31 $0
2011-02-28 $0
2010-11-30 $0
2010-08-31 $-2
2010-05-31 $0
2010-02-28 $0
2009-11-30 $-0
2009-08-31 $0
2009-05-31 $0
2009-02-28 $0
Sector Industry Market Cap Revenue
Medical Medical Services $0.074B $0.031B
CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $95.295B 11.82
Cencora (COR) United States $49.256B 18.17
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.251B 0.00
ICON (ICLR) Ireland $16.821B 14.98
Viatris (VTRS) United States $15.517B 4.78
Avantor (AVTR) United States $14.688B 22.02
Revvity (RVTY) United States $14.573B 25.32
BioMerieux (BMXMF) France $12.666B 0.00
CochLear (CHEOY) Australia $12.640B 0.00
Solventum (SOLV) United States $12.100B 0.00
Medpace Holdings (MEDP) United States $11.250B 31.69
Charles River Laboratories (CRL) United States $10.562B 20.41
Doximity (DOCS) United States $9.814B 58.09
HealthEquity (HQY) United States $8.278B 44.93
Sonic Healthcare (SKHHY) Australia $8.023B 0.00
Bausch + Lomb (BLCO) Canada $6.959B 32.39
Life Times (LTH) United States $5.005B 33.12
Sotera Health (SHC) United States $4.339B 23.21
Organon (OGN) United States $4.020B 4.05
BrightSpring Health Services (BTSG) United States $3.423B 72.82
Surgery Partners (SGRY) United States $3.242B 36.96
PACS (PACS) United States $3.123B 0.00
Concentras Parent (CON) United States $2.623B 0.00
Alignment Healthcare (ALHC) United States $2.450B 0.00
Ardent Health Partners (ARDT) United States $2.426B 0.00
Premier (PINC) United States $2.317B 11.56
GeneDx Holdings (WGS) United States $2.156B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GoodRx Holdings (GDRX) United States $1.768B 46.60
Teladoc Health (TDOC) United States $1.648B 0.00
Pediatrix Medical (MD) United States $1.307B 12.79
CareDx (CDNA) United States $1.222B 0.00
Progyny (PGNY) United States $1.184B 23.97
Establishment Labs Holdings (ESTA) $1.101B 0.00
AMN Healthcare Services Inc (AMN) United States $0.937B 6.34
Embecta (EMBC) United States $0.889B 5.92
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.775B 0.00
InnovAge Holding (INNV) United States $0.741B 0.00
SBC Medicals (SBC) United States $0.717B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
DocGo (DCGO) United States $0.433B 16.27
Sonida Senior Living (SNDA) United States $0.419B 0.00
Enhabit (EHAB) United States $0.383B 33.09
COMPASS Pathways (CMPS) United Kingdom $0.341B 0.00
LifeMD (LFMD) United States $0.303B 0.00
ModivCare (MODV) United States $0.241B 13.05
Sera Prognostics (SERA) United States $0.233B 0.00
Beauty Health (SKIN) United States $0.229B 0.00
Biodesix (BDSX) United States $0.204B 0.00
Nutex Health (NUTX) United States $0.177B 0.00
MultiPlan (MPLN) United States $0.133B 0.00
Ascend Wellness Holdings (AAWH) United States $0.120B 0.00
So-Young (SY) China $0.083B 19.99
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.050B 0.00
NeueHealth (NEUE) United States $0.039B 1.02
Co-Diagnostics (CODX) United States $0.035B 0.00
Pheton Holdings (PTHL) China $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
IceCure Medical (ICCM) Israel $0.025B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.011B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00